Atlas Trials

A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression

Clinical trial NCT06285916 · COMPLETED

Trial details

NCT number
NCT06285916
Sponsor
TWi Biotechnology, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Depression, PostpartumPostpartum DepressionPost-partum DepressionPostnatal DepressionPost-Natal Depression
Start date
2024-03-28
Primary completion
2025-09-11
Enrollment
93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.